Binawaluya Cardiac Hospital Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2015
NCT02146664
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Binawaluya Cardiac Hospital, Jakarta

Active Ingredients

Drugs in Phase 3 Trials (1)

Lumbricus rubellus (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Non-ST Elevated Myocardial Infarction (Phase 3)

ST Elevation Myocardial Infarction (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1